Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
3(38%)
Results Posted
25%(1 trials)

Phase Distribution

Ph phase_1
1
13%
Ph not_applicable
3
38%
Ph phase_3
3
38%
Ph phase_4
1
13%

Phase Distribution

1

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 3Large-scale testing
3(37.5%)
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
3(37.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(4)
Completed(4)

Detailed Status

Completed4
Recruiting3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (12.5%)
Phase 33 (37.5%)
Phase 41 (12.5%)
N/A3 (37.5%)

Trials by Status

completed450%
recruiting338%
not_yet_recruiting113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8